A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines
Clinical trial NCT06308198 · COMPLETED
Trial details
- NCT number
- NCT06308198
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-29
- Primary completion
- 2025-02-26
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.